Skip to main content

Table 5 QoL scores at baseline, 3, 6, 12 and 96 months for the experimental and the control group

From: Naprapathy versus orthopaedic standard care for common musculoskeletal disorders: an 8-year follow-up of a pragmatic randomized controlled trial in Sweden

Group

Month

Sum

Number of participants

Mean value/participant with 95% CI

Control group

0

26.108

38

0.687 (0.636–0.738)

 

3

26.417

38

0.695 (0.647–0.743)

 

6

27.532

38

0.725 (0.675–0.774)

 

12

26.909

37

0.727 (0.675–0.779)

 

96

26.372

37

0.713 (0.668–0.758)

Experimental group

0

26.225

40

0.656 (0.620–0.691)

 

3

29.490

40

0.737 (0.694–0.780)

 

6

30.154

40

0.754 (0.707–0.800)

 

12

29.282

38

0.771 (0.722–0.819)

 

96

31.288

38

0.823 (0.785–0.862)

  1. Confidence intervals 95%, p-values < 0.01
  2. The maximum, most preferrable score of QoL is 1.0